Rankings
▼
Calendar
BOLD Q1 2023 Earnings — Boundless Bio, Inc. Revenue & Financial Results | Market Cap Arena
BOLD
Boundless Bio, Inc.
$26M
Q1 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$12M
Net Income
-$12M
EPS (Diluted)
$-0.53
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$12M
Free Cash Flow
-$12M
Stock-Based Comp.
$615,000
← FY 2023
All Quarters
Q2 2023 →